138 related articles for article (PubMed ID: 6413483)
1. In-vitro activity of azlocillin and other beta-lactam antibiotics against enterococci.
Grimm H
J Antimicrob Chemother; 1983 May; 11 Suppl B():43-9. PubMed ID: 6413483
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of modern penicillins and cephalosporins against enterococci.
Haller I; Heinrich S
Arzneimittelforschung; 1982; 32(7):756-9. PubMed ID: 6812597
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of enterococci to beta-lactam antibiotics, co-trimoxazole, nitrofurantoin, tetracycline and doxycycline.
Grimm H
Arzneimittelforschung; 1983; 33(3):419-23. PubMed ID: 6603227
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
Gootz TD; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
[TBL] [Abstract][Full Text] [Related]
5. Susceptibilities of enterococci to twelve antibiotics.
Tofte RW; Solliday JA; Crossley KB
Antimicrob Agents Chemother; 1984 Apr; 25(4):532-3. PubMed ID: 6428309
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Machka K; Dickert H; Braveny I
Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
Thabaut A; Durosoir JL; Saliou P
Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690
[TBL] [Abstract][Full Text] [Related]
8. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.
Kaye D
Arch Intern Med; 1982 Oct; 142(11):2006-9. PubMed ID: 6812524
[TBL] [Abstract][Full Text] [Related]
9. Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Neu HC; Labthavikul P
J Antimicrob Chemother; 1982 Jan; 9 Suppl A():101-6. PubMed ID: 6281229
[No Abstract] [Full Text] [Related]
10. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
Traub WH
Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
[TBL] [Abstract][Full Text] [Related]
11. Different activity of penicillins and cephalosporins on enterococci.
Fontana R; Rossi L; Gesu GP; Maresu F; Satta G; Stefani S
Chemioterapia; 1987 Jun; 6(2 Suppl):60-1. PubMed ID: 3151354
[No Abstract] [Full Text] [Related]
12. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Monteil H; Peladan F; Zinsius M
Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
[TBL] [Abstract][Full Text] [Related]
13. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
Eliopoulos GM; Moellering RC
Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.
Weinstein MP; Mirrett S; Kannangara S; Monahan J; Harrell LJ; Wilson AC; Reller LB
J Clin Microbiol; 2004 Aug; 42(8):3747-51. PubMed ID: 15297525
[TBL] [Abstract][Full Text] [Related]
17. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
Greenwood D; Eley A
J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
[TBL] [Abstract][Full Text] [Related]
18. [Current status of determining bacteria and resistance in urinary tract infections].
Ritzerfeld W; Fegeler W
Urologe A; 1984 May; 23(3):130-3. PubMed ID: 6539985
[TBL] [Abstract][Full Text] [Related]
19. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
20. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
